BioScience Managers partnership video: strategic investment Supporting clinical development

BioScience Managers has published a video case study exploring their investment partnership with Cynata and how strategic capital is advancing next-generation stem cell therapies. The video features insights from Jeremy Curnock Cook, Founder of BioScience Managers, and CEO Dr Kilian Kelly on the role of long-term strategic capital in clinical-stage biotechnology. BioScience Managers invested at least $10 million in Cynata in December 2020 through the BioScience Managers Translation Fund, combining private capital with Australian Government co-investment from the Biomedical Translation Fund.

The video explores how the partnership has enabled Cynata to progress multiple clinical development programs across global sites, and how BioScience Managers' deep sector expertise and long-term investment horizon align with the realities of developing novel cell therapies. Dr Kelly notes in the video that clinical development requires partners who thoroughly understand the field and can take a long-term view, adding that BioScience Managers has actively supported business development by opening doors to new opportunities across complementary technologies and geographies. The case study demonstrates how the Biomedical Translation Fund model leverages Commonwealth co-investment to help Australian biomedical companies progress from clinical stage to commercial reality.

Watch the video: https://tinyurl.com/3nvy6kpk